Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. (Q53910457)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. |
scientific article |
Statements
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. (English)
Clevenbergh P
Durant J
Halfon P
del Giudice P
Mondain V
Montagne N
Schapiro JM
Boucher CA
Dellamonica P
1 March 2000
5
1
65-70